It is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, which means that it stimulates the release of insulin and inhibits the release of glucagona hormone that raises blood sugar levels
van Geel AN, den Bakker MA, Kirkels W, Horenblas S, Kroon BB, de Wilt JH, Eggermont AM, Mooi WJ, van der Aa MN: Prognosis of primary mucosal penile melanoma: a series of 19 Dutch patients and 47 patients from the literature
Here is a general timeline of what most patients can expect: Months 12+: Weight loss may begin to slow down as you approach a healthy body weight
Ramdial K, Franco MC, Estevez AG
Immune Support: Enhances overall immune function
Contact the pharmacy to report the issue and request a replacement